ZEROCIT 50 mg TABLETS FOR DOGS
ZEROCIT 50 mg TABLETS FOR DOGS
Authorised
- Praziquantel
Product identification
Medicine name:
ZEROCIT 50 mg TABLETS FOR DOGS
ZEROCIT 50 mg COMPRIMIDOS PARA PERROS
Active substance:
- Praziquantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Praziquantel50.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Package description:
- Carton containing 2 blisters of 10 tablets (20 tablets)
- Carton containing 4 blisters of 10 tablets (40 tablets)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Cyton AH Biosciences GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Pantex Holland B.V.
Responsible authority:
- Spanish Agency Of Medicines And Medical Devices
Authorisation number:
- 4378 ESP
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0437/001
Concerned member states:
-
Hungary
-
Ireland
-
Italy
-
Netherlands
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 24/04/2025
Spanish (PDF)
Published on: 13/03/2025
es-PUAR-esv0437001-dcp-zerocit-50-mg-comprimidos-para-perros-es.pdf
Spanish (PDF)
Download Published on: 13/03/2025
How useful was this page?:
